Skip to content
2000
Volume 12, Issue 2
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

A series of hybrids of 3-hydroxy-indolin-2-one and 2,3-dihydroquinolin-4(1H) -one were synthesized and their anti-proliferative activities against two human cancer cell lines were initially evaluated. Compound 7g was selected for further study and demonstrated moderate anti-proliferative activities against four human cancer cell lines. Meanwhile, 7g had inhibitory effects on the growth of SGC-7901 cells in dosage-and time-dependent manners and the cancer cells appeared morphological changes. Moreover, 7g was more effective in the inhibition of xenografted tumor in vivo growth and mice treated with 7g showed more weight gain than 5-FU-treated mice over the treatment period, suggesting a lower toxic effect than 5-FU. After treatment with 7g, the tumor showed typical morphological changes as evaluated by H&E staining.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180811666140909010017
2015-02-01
2025-05-30
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180811666140909010017
Loading

  • Article Type:
    Research Article
Keyword(s): 2; 3-Dihydroquinolin-4(1H)-one; 3-Hydroxy-indolin-2-one; anticancer; hybrid; isatin; synthesis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test